SC-14266

Known as: SC 14266, SC14266 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1964-2005
01219642005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
1980
Chronic administration of potassium canrenoate (SC-14266), a water-soluble anti-aldosterone agent, increased serum LH levels in… (More)
  • table 1
Is this relevant?
1976
1976
The effects of treatment with a spironolactone derivative (SC 14266) for 9 experimental weeks on blood pressure and plasma renin… (More)
Is this relevant?
1976
1976
1. A competitive "mineralocorticoid" receptor-binding technique has been used to study plasma "mineralocoroticoid" activity in… (More)
Is this relevant?
1976
1976
Chronic experiments were carried out on three groups of rats to evaluate tissue and electrolyte effects of a mineralocorticoid… (More)
Is this relevant?
1975
1975
1. Necturus maculosus kidney function has been examined using standard clearance techniques and renal tubular micropuncture… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1975
1975
Potassium prorenoate (SC-23992) is a water-soluble steroidal compound with the ability to antagonize the sodium-retaining and… (More)
Is this relevant?
1973
1973
Histone acetylation in the kidney of the adrenalectomized rat was increased 5 min after a physiological dose of aldosterone. The… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
1969
1969
This study was designed to examine the effect of adrenal steroid hormones on the response of the toad bladder to vasopressin… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1964
1964
 
Is this relevant?